Miral Dental Clinics Co. posted SAR 6.5 million in net profit for H1 2024, a rise of 8% from SAR 6.1 million a year ago.
Item | 6m 2023 | 6m 2024 | Change |
---|---|---|---|
Revenues | 30.70 | 33.98 | 10.7 % |
Gross Income | 11.24 | 12.15 | 8.0 % |
Operating Income | 6.77 | 8.00 | 18.2 % |
Net Income | 6.06 | 6.54 | 7.9 % |
Average Shares | 2.00 | 2.00 | - |
EPS (Riyals) | 3.03 | 3.27 | 7.9 % |
Item | H1 2023 | H1 2024 | Change |
---|---|---|---|
Revenues | 30.70 | 33.98 | 10.7 % |
Gross Income | 11.24 | 12.15 | 8.0 % |
Operating Income | 6.77 | 8.00 | 18.2 % |
Net Income | 6.06 | 6.54 | 7.9 % |
Average Shares | 2.00 | 2.00 | - |
EPS (Riyals) | 3.03 | 3.27 | 7.9 % |
Item | H2 2023 | H1 2024 | Change |
---|---|---|---|
Revenues | 34.67 | 33.98 | (2.0 %) |
Gross Income | 12.95 | 12.15 | (6.2 %) |
Operating Income | 6.40 | 8.00 | 25.1 % |
Net Income | 5.91 | 6.54 | 10.7 % |
Average Shares | 2.00 | 2.00 | - |
EPS (Riyals) | 2.95 | 3.27 | 10.7 % |
The annual profit growth was driven by the 11% year-on-year (YoY) revenue hike to SAR 3.28 million on the expanded number of clinics in the Al-Malqa branch and the higher doctor count at the main branches of Al-Tahlia and Al-Malqa districts.
Shareholders' equity (no minority interest) climbed to SAR 49.42 million, compared to SAR 36.65 million in H1 2023.
Historical Data |
|||
Period |
Revenue (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
H1 2022 |
26.52 |
5.27 |
2.64 |
H2 2022 |
31.94 |
5.97 |
2.98 |
H1 2023 |
30.70 |
6.06 |
3.03 |
H2 2023 |
34.67 |
5.91 |
2.95 |
H1 2024 |
33.97 |
6.54 |
3.27 |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
H1 2020 | - | - | - | - | - | - |
H2 2020 | - | - | - | - | - | - |
2020 | - | - | - | - | - | - |
H1 2021 | - | - | - | - | - | - |
H2 2021 | - | - | - | - | - | - |
2021 | 54.55 | - | 18.14 | - | 9.96 | - |
H1 2022 | - | - | - | - | - | - |
H2 2022 | - | - | - | - | - | - |
2022 | 58.46 | 7.2 % | 20.58 | 13.5 % | 13.10 | 31.6 % |
H1 2023 | 30.70 | - | 11.24 | - | 6.77 | - |
H2 2023 | 34.67 | - | 12.95 | - | 6.40 | - |
2023 | 65.37 | 11.8 % | 24.19 | 17.6 % | 13.17 | 0.5 % |
H1 2024 | 33.98 | 10.7 % | 12.15 | 8.0 % | 8.00 | 18.2 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
2020 | - | - | - | - | - | - |
2021 | 54.55 | - | 18.14 | - | 9.96 | - |
2022 | 58.46 | 7.2 % | 20.58 | 13.5 % | 13.10 | 31.6 % |
2023 | 65.37 | 11.8 % | 24.19 | 17.6 % | 13.17 | 0.5 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
H1 2015 | - | - | - | - | - | - |
H2 2015 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
H1 2016 | - | - | - | - | - | - |
H2 2016 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
H1 2017 | - | - | - | - | - | - |
H2 2017 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
H1 2018 | - | - | - | - | - | - |
H2 2018 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
H1 2019 | - | - | - | - | - | - |
H2 2019 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
H1 2020 | - | - | - | - | - | - |
H2 2020 | - | - | - | - | - | - |
2020 | - | - | - | - | - | - |
H1 2021 | - | - | - | - | - | - |
H2 2021 | - | - | - | - | - | - |
2021 | 9.17 | - | 4.58 | - | 9.17 | 4.58 |
H1 2022 | - | - | - | - | - | - |
H2 2022 | - | - | - | - | - | - |
2022 | 11.24 | 22.6 % | 5.62 | (0.84) | 12.08 | 6.04 |
H1 2023 | 6.06 | - | 3.03 | - | 6.06 | 3.03 |
H2 2023 | 5.91 | - | 2.95 | - | 5.91 | 2.95 |
2023 | 11.97 | 6.5 % | 5.99 | - | 11.97 | 5.99 |
H1 2024 | 6.54 | 7.9 % | 3.27 | (1.14) | 7.68 | 3.84 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2014 | - | - | - | - | - | - |
2015 | - | - | - | - | - | - |
2016 | - | - | - | - | - | - |
2017 | - | - | - | - | - | - |
2018 | - | - | - | - | - | - |
2019 | - | - | - | - | - | - |
2020 | - | - | - | - | - | - |
2021 | 9.17 | - | 4.58 | - | 9.17 | 4.58 |
2022 | 11.24 | 22.6 % | 5.62 | (0.84) | 12.08 | 6.04 |
2023 | 11.97 | 6.5 % | 5.99 | - | 11.97 | 5.99 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2015 | - | - | - |
H2 2015 | - | - | - |
2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
2020 | - | - | - |
H1 2021 | - | - | - |
H2 2021 | - | - | - |
2021 | 33.25 % | 25.85 % | 16.81 % |
H1 2022 | - | - | - |
H2 2022 | - | - | - |
2022 | 35.21 % | 29.96 % | 20.67 % |
H1 2023 | - | - | - |
H2 2023 | 37.01 % | 26.83 % | 18.31 % |
2023 | 37.01 % | 26.83 % | 18.31 % |
H1 2024 | 36.56 % | 27.79 % | 19.79 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021 | 33.25 % | 25.85 % | 16.81 % |
2022 | 35.21 % | 29.96 % | 20.67 % |
2023 | 37.01 % | 26.83 % | 18.31 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
H1 2021 | - | - | - |
H2 2021 | - | - | - |
H1 2022 | - | - | - |
H2 2022 | - | - | - |
H1 2023 | 36.63 % | 28.59 % | 19.75 % |
H2 2023 | 37.36 % | 25.26 % | 17.04 % |
H1 2024 | 35.75 % | 30.37 % | 22.60 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
H1 2015 | - | - | - | - |
H2 2015 | - | - | - | - |
H1 2016 | - | - | - | - |
H2 2016 | - | - | - | - |
H1 2017 | - | - | - | - |
H2 2017 | - | - | - | - |
H1 2018 | - | - | - | - |
H2 2018 | - | - | - | - |
H1 2019 | - | - | - | - |
H2 2019 | - | - | - | - |
H1 2020 | - | - | - | - |
H2 2020 | - | - | - | - |
H1 2021 | - | - | - | - |
H2 2021 | - | - | - | - |
H1 2022 | - | - | - | - |
H2 2022 | - | - | - | - |
H1 2023 | 2.00 | - | - | 17.94 |
H2 2023 | 2.00 | 5.99 | 5.99 | 20.92 |
H1 2024 | 2.00 | 6.22 | 6.79 | 24.71 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2014 | - | - | - | - |
2015 | - | - | - | - |
2016 | - | - | - | - |
2017 | - | - | - | - |
2018 | - | - | - | - |
2019 | - | - | - | - |
2020 | - | - | - | - |
2021 | 2.00 | 4.58 | 4.58 | 8.97 |
2022 | 2.00 | 5.62 | 6.04 | 15.02 |
2023 | 2.00 | 5.99 | 5.99 | 20.92 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
H1 2015 | - | - | - |
H2 2015 | - | - | - |
H1 2016 | - | - | - |
H2 2016 | - | - | - |
H1 2017 | - | - | - |
H2 2017 | - | - | - |
H1 2018 | - | - | - |
H2 2018 | - | - | - |
H1 2019 | - | - | - |
H2 2019 | - | - | - |
H1 2020 | - | - | - |
H2 2020 | - | - | - |
H1 2021 | - | - | - |
H2 2021 | - | - | - |
H1 2022 | - | - | - |
H2 2022 | - | - | - |
H1 2023 | - | - | - |
H2 2023 | - | - | - |
H1 2024 | 16.07 | 14.72 | 4.05 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2014 | - | - | - |
2015 | - | - | - |
2016 | - | - | - |
2017 | - | - | - |
2018 | - | - | - |
2019 | - | - | - |
2020 | - | - | - |
2021 | - | - | - |
2022 | - | - | - |
2023 | - | - | - |
Q2 2023
2024
Period | Revenue from providing dental services | Revenue from individuals | Revenue from insurance companies |
---|---|---|---|
Q2 2022 | - | 21.15 | 5.36 |
Q4 2022 | - | 10.76 | 15.46 |
Q2 2023 | 30.70 | - | - |
Period | Revenue from providing dental services | Revenue from individuals | Revenue from insurance companies |
---|---|---|---|
2021 | - | 38.91 | 15.65 |
2022 | - | 37.63 | 20.82 |
2023 | - | 39.15 | 26.22 |
Current | |
Market Cap (M Riyal) | 197.00 |
Enterprise Value (EV) (M) | 171.56 |
Shares Outstanding ((M)) | 2.00 |
Book Value (BV) ( Riyal) | 20.92 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 16.46 |
Price/book | 4.71 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}